VION Insider Trading Activity and SEC Form 4 Filings
VION insider trading summary
No open-market insider purchases or sales of Vion Pharmaceuticals Inc (VION) have been reported on SEC Form 4 in the past 12 months.
Latest VION insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 9, 2009 | Ivan King | VP Research and Development | Sell | $49K (45,166 @ $1.09) |
| Sep 8, 2009 | Ann Lee Cahill | VP Clinical Development | Sell | $54K (70,000 @ $0.78) |
| Mar 15, 2007 | Aileen Ryan | VP Regulatory Affairs | Buy | $3K (1,500 @ $1.68) |
| Mar 13, 2007 | Kevin Rakin | Director | Buy | $24K (15,000 @ $1.59) |
| Mar 12, 2007 | George Bickerstaff | Director | Buy | $18K (10,000 @ $1.77) |
| Mar 12, 2007 | George Bickerstaff | Director | Buy | $24K (13,900 @ $1.75) |
| Mar 12, 2007 | George Bickerstaff | Director | Buy | $11K (6,600 @ $1.74) |
| Mar 12, 2007 | George Bickerstaff | Director | Buy | $34K (19,500 @ $1.76) |
| Mar 9, 2007 | Ian Williams | Director | Buy | $8K (5,000 @ $1.66) |
| Mar 8, 2007 | Howard B Johnson | President and CFO | Buy | $20K (12,800 @ $1.55) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.